ethinyl estradiol has been researched along with piperidines in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.26) | 18.7374 |
1990's | 9 (47.37) | 18.2507 |
2000's | 5 (26.32) | 29.6817 |
2010's | 2 (10.53) | 24.3611 |
2020's | 2 (10.53) | 2.80 |
Authors | Studies |
---|---|
Veldhuis, JD | 1 |
Bryant, HU; Cole, HW; Draper, MW; Fuchs-Young, R; Glasebrook, AL; Magee, DE; Rippy, MK; Short, LL; Termine, JD | 1 |
Draper, MW; Flowers, DE; Huster, WJ; Neild, JA; Zerbe, RL | 1 |
Bryant, HU; Kim, J; Sato, M; Short, LL; Slemenda, CW | 1 |
Bryant, HU; Sato, M; Turner, CH | 1 |
Bekele, A; Bendele, R; Bensch, WR; Black, LJ; Cullinan, GJ; Kauffman, RF; Magee, DE; Rowley, ER; Sato, M; Williams, DC | 1 |
Bryant, HU; Evans, GL; Magee, DE; Turner, RT | 1 |
Carver, JM; Lundeen, SG; McKean, ML; Winneker, RC | 1 |
Cheskis, BJ; Karathanasis, S; Lyttle, CR | 1 |
Andersson-Ross, C; Barkhem, T; Höglund, M; Nilsson, S | 1 |
Bryant, HU; Burris, LL; Glasebrook, AL; Palkowitz, AD; Pearce, HL; Peer, C; Sporn, MB; Starling, JJ; Suh, N; Wang, Y; Williams, C | 1 |
Amari, G; Armani, E; Caruso, PL; Civelli, M; Delcanale, M; Galbiati, E; Ghirardi, S | 1 |
Arshad, M; Ghosh, R; Sawlani, V; Sengupta, S; Sharma, S; Singh, MM | 1 |
Adrian, MD; Bryant, HU; Cohen, IR; Dodge, JA; Donnelly, KB; Draper, MW; Geiser, AG; Henck, JW; Hummel, CW; McCann, DJ; Oldham, SW; Rudmann, DG; Sato, M; Shepherd, TA; Wallace, OB | 1 |
Armamento-Villareal, R; Brodt, MD; Caruso, PL; Civelli, M; Civitelli, R; Galbiati, E; Halstead, LR; Mueller, C; Napoli, N; Nawaz, A; Sheikh, S; Silva, MJ | 1 |
Mayer, GD; Notch, EG | 1 |
Alvey, CW; Krishnaswami, S; Menon, S; Petit, W; Riese, R; Shi, H; Wang, R | 1 |
Cordoba, R; de Jong, J; Dlugosz-Danecka, M; Hellemans, P; Jiao, J; Jurczak, W; Mitselos, A; Ouellet, D; Panizo, C; Sukbuntherng, J; Wrobel, T | 1 |
Fukuda, K; Ieda, M; Kurokawa, J; Sakamoto, K; Sugimoto, M; Sugimoto, S; Suzuki, T; Tamura, F; Yamaguchi, M | 1 |
3 trial(s) available for ethinyl estradiol and piperidines
Article | Year |
---|---|
Antiestrogenic properties of raloxifene.
Topics: Adult; Analysis of Variance; Drug Interactions; Estradiol; Estrogen Antagonists; Ethinyl Estradiol; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Male; Middle Aged; Piperidines; Pituitary Hormones, Anterior; Prolactin; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin; Tamoxifen; Testosterone; Transcortin | 1995 |
Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Young Adult | 2016 |
Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6.
Topics: Adenine; Administration, Oral; Adult; Aged; Aged, 80 and over; Area Under Curve; Bupropion; Contraceptives, Oral; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Drug Interactions; Ethinyl Estradiol; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Levonorgestrel; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Metabolic Clearance Rate; Midazolam; Middle Aged; Piperidines; Waldenstrom Macroglobulinemia | 2020 |
16 other study(ies) available for ethinyl estradiol and piperidines
Article | Year |
---|---|
Mechanisms subserving the bipotential actions of estrogen on ovarian cells: studies with a selective anti-estrogen, LY156758, and the sparingly metabolizable estrogen agonist, moxestrol.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Ovary; Piperidines; Pregnenolone; Progesterone; Raloxifene Hydrochloride; Receptors, Estradiol; Swine | 1986 |
Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptor.
Topics: Animals; Bone Density; Breast Neoplasms; Cell Division; Cholesterol; Ethinyl Estradiol; Female; Humans; Middle Aged; Organ Size; Organ Specificity; Piperidines; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Uterus | 1995 |
Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
Topics: Aging; Animals; Bone Density; Ethinyl Estradiol; Female; Lipids; Organ Size; Osteoporosis; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tibia; Tomography, X-Ray Computed; Uterus | 1995 |
Raloxifene preserves bone strength and bone mass in ovariectomized rats.
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Densitometry; Estrogens; Ethinyl Estradiol; Female; Femur Neck; Lumbar Vertebrae; Organ Size; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Time Factors; Uterus | 1994 |
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Body Weight; Bone Density; Bone Resorption; Calcium; Cholesterol; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Estrogen Antagonists; Ethinyl Estradiol; Female; Hypertrophy; Ovariectomy; Phosphorus; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Triglycerides; Uterus | 1994 |
Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.
Topics: Animals; Bone and Bones; Bone Diseases, Metabolic; Dose-Response Relationship, Drug; Estrogen Antagonists; Ethinyl Estradiol; Female; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley | 1996 |
Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels.
Topics: Animals; Cholesterol; Dexamethasone; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogens; Ethinyl Estradiol; Female; Fulvestrant; Lipids; Ovariectomy; Piperidines; Progesterone; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1997 |
Estrogen receptor ligands modulate its interaction with DNA.
Topics: DNA-Binding Proteins; Estradiol; Estrogen Antagonists; Ethinyl Estradiol; Fulvestrant; Humans; Ligands; Piperidines; Protein Binding; Raloxifene Hydrochloride; Receptors, Estrogen; Regulatory Sequences, Nucleic Acid; Tamoxifen; Transcription Factors | 1997 |
Characterization of the "estrogenicity" of tamoxifen and raloxifene in HepG2 cells: regulation of gene expression from an ERE controlled reporter vector versus regulation of the endogenous SHBG and PS2 genes.
Topics: Alkaline Phosphatase; Carcinoma, Hepatocellular; Clone Cells; Estradiol; Estradiol Congeners; Estrogen Antagonists; Ethinyl Estradiol; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Kinetics; Liver Neoplasms; Piperidines; Placenta; Pregnancy; Protein Biosynthesis; Proteins; Raloxifene Hydrochloride; Receptors, Estrogen; Recombinant Fusion Proteins; Sex Hormone-Binding Globulin; Tamoxifen; Tetradecanoylphorbol Acetate; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1997 |
Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.
Topics: Animals; Anticarcinogenic Agents; Binding, Competitive; Cell Division; Drug Interactions; Estradiol; Estradiol Congeners; Estrogen Antagonists; Ethinyl Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Piperidines; Rats; Receptors, Estrogen; Tamoxifen; Thiophenes; Tumor Cells, Cultured; Uterus | 2001 |
Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
Topics: Animals; Benzopyrans; Bone Density; Cholesterol; Dose-Response Relationship, Drug; Eosinophil Peroxidase; Estradiol Congeners; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Ovariectomy; Peroxidases; Piperidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Uterus | 2002 |
In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
Topics: Animals; Autopsy; Benzopyrans; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Calcium; Centchroman; Chick Embryo; Densitometry; Disease Models, Animal; Epithelial Cells; Ethinyl Estradiol; Female; Femur; Osteocalcin; Osteoporosis; Ovary; Parathyroid Hormone; Piperidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Tibia | 2004 |
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
Topics: Animals; Bone and Bones; Cell Line, Tumor; Ethinyl Estradiol; Female; Humans; Kinetics; Naphthalenes; Ovariectomy; Ovulation Induction; Piperidines; Rats; Receptors, Estrogen; Sexual Maturation; Uterus | 2005 |
A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Topics: Absorptiometry, Photon; Amino Acids; Animals; Benzopyrans; Biomechanical Phenomena; Blood; Body Composition; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Compressive Strength; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Femur; Femur Neck; Lumbar Vertebrae; Organ Size; Osteoclasts; Osteogenesis; Ovariectomy; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed; Triglycerides; Uterus; Weight-Bearing | 2005 |
Efficacy of pharmacological estrogen receptor antagonists in blocking activation of zebrafish estrogen receptors.
Topics: Animals; Cell Line, Tumor; Estradiol; Ethinyl Estradiol; Fulvestrant; Humans; Piperidines; Pyrazoles; Pyrimidines; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Zebrafish | 2011 |
The Effect of a Synthetic Estrogen, Ethinylestradiol, on the hERG Block by E-4031.
Topics: Estradiol Congeners; Ether-A-Go-Go Potassium Channels; Ethinyl Estradiol; HEK293 Cells; Humans; Ion Channel Gating; Piperidines; Pyridines | 2021 |